Navigation Links
Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results
Date:2/23/2010

llaborative relationship with Bayer; market acceptance and the rate of adoption of our products; pharmaceutical pricing and reimbursement pressures; serious adverse side effects, if they are associated with Nexavar; government regulation; possible failure to realize the anticipated benefits of business acquisitions or strategic investments; protection of our intellectual property; the indebtedness incurred through the sale of our 4.0% convertible senior notes due 2016; product liability risks; and the anticipated benefits of the acquisition of Proteolix.  Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2009 filed with the Securities and Exchange Commission, under the heading "Risk Factors" for a more detailed description of these and other risks, as well as the company's subsequent quarterly reports on Form 10-Q.  Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release.  Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

(See attached tables.)

    
    
                           ONYX PHARMACEUTICALS, INC.              
                CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS   
                    (In thousands, except per share amounts)
                                (unaudited)                             
                                             
                                       Three Months           Year 
                                          Ended               Ended
                                       December 31,        Decembe
'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
2. Jazz Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 3, 2010
3. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
4. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
5. Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains
6. Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks
7. Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
8. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
9. Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
10. Transdel Pharmaceuticals Announces Management Reorganization
11. Merz Pharmaceuticals Introduces New Mederma(R) Stretch Marks Therapy Now Available in Drugstores Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... LAWRENCEVILLE, N.J. , July 24, 2014 /PRNewswire/ ... announced today positive interim data from its ongoing ... Recurrent Chest Wall Breast Cancer (RCWBC).  The trial ... U.S. clinical sites and is evaluating ThermoDox in ... enrolled and treated, 10 were eligible for evaluation of ...
(Date:7/24/2014)... 24, 2014 , Revenues from continuing ... , Adjusted diluted EPS from continuing operations of $1.08, up ... continuing operations of $0.92, 7% below prior year , ... year , Full year 2014 revenues now expected to ... previously , Full year 2014 adjusted diluted EPS range ...
(Date:7/24/2014)... Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... 30, 2014.  The Company reported second quarter net sales ... 0.9% constant currency over the second quarter of 2013.  ... reported and $1.49 adjusted, an increase of 4.2% adjusted ... second quarter was marked by solid sales growth in ...
Breaking Medicine Technology:Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer 2Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer 3Quest Diagnostics Reports Second Quarter 2014 Financial Results 2Quest Diagnostics Reports Second Quarter 2014 Financial Results 3Quest Diagnostics Reports Second Quarter 2014 Financial Results 4Quest Diagnostics Reports Second Quarter 2014 Financial Results 5Quest Diagnostics Reports Second Quarter 2014 Financial Results 6Quest Diagnostics Reports Second Quarter 2014 Financial Results 7Quest Diagnostics Reports Second Quarter 2014 Financial Results 8Quest Diagnostics Reports Second Quarter 2014 Financial Results 9Quest Diagnostics Reports Second Quarter 2014 Financial Results 10Quest Diagnostics Reports Second Quarter 2014 Financial Results 11Quest Diagnostics Reports Second Quarter 2014 Financial Results 12Quest Diagnostics Reports Second Quarter 2014 Financial Results 13Quest Diagnostics Reports Second Quarter 2014 Financial Results 14Quest Diagnostics Reports Second Quarter 2014 Financial Results 15Quest Diagnostics Reports Second Quarter 2014 Financial Results 16Quest Diagnostics Reports Second Quarter 2014 Financial Results 17Quest Diagnostics Reports Second Quarter 2014 Financial Results 18Quest Diagnostics Reports Second Quarter 2014 Financial Results 19Quest Diagnostics Reports Second Quarter 2014 Financial Results 20Quest Diagnostics Reports Second Quarter 2014 Financial Results 21Quest Diagnostics Reports Second Quarter 2014 Financial Results 22Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 2Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 3Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 4Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 5Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 6Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 7Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 8Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 9Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 10Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 11Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 12Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results 13
... U.S. District Court Judge Sidney A. Fitzwater has given ... lawsuit that left hundreds of premature babies with life threatening medical conditions and ... will receive compensation under the settlement. , ... "It took years of litigation and research to pry relevant information from people ...
... June 21 One of the leading cancer centers in ... region to introduce fast and efficient RapidArc® radiotherapy treatments from Varian Medical ... treated nine brain cancer, prostate cancer and head & neck cancer patients ... to roll out the technology for many more indications. , ...
Cached Medicine Technology:Fort Worth Attorney Dwain Dent Comments on Final Judgment in Case That Left Hundreds of Babies Dead or Injured 2Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 2Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 3
(Date:7/24/2014)... Texas (PRWEB) July 24, 2014 ... provides key market data on the North America ... millions of US dollars, and volume (in units) ... market categories Spinal Fusion, Vertebral Compression Fracture Repair ... Companies in North America Spinal Surgery Market:, ...
(Date:7/24/2014)... Thursday 24 July 2014. LSE Health and the ... of Cardiology (ESC) are pleased to announce the ... professionals working in the field of cardiovascular sciences. ... Management in Cardiovascular Sciences aims to equip cardiovascular ... policy skills required to take on advisory, management ...
(Date:7/24/2014)... associated with upsurges in hospital admissions among young people. ... is published online today in the scientific journal ... British Columbia Associate Professor of Psychiatry Dr. Russ Callaghan, ... a five-year period (2002-07) involving people aged 12 to ... in which Ontarians turned 19 the legal drinking ...
(Date:7/24/2014)... July 24, 2014 Does your pet have ... work with an outstanding veterinary technician, practice manager or receptionist? ... give their right paw for furry friends? Recognize them by ... , Petplan – North America's best-loved pet insurance ... which honor the dedicated and exceptional pet health heroes who ...
(Date:7/24/2014)... 2014 (HealthDay News) -- A new study estimates that ... over the past year due to the Affordable Care ... expanded eligibility for Medicaid, the federal insurance program for ... Obamacare, states had a choice about expanding eligibility. ... set us on a path toward achieving that goal," ...
Breaking Medicine News(10 mins):Health News:Spinal Surgery Market in North America Forecast to 2020 New Report Available at ReportsnReports.com 2Health News:Spinal Surgery Market in North America Forecast to 2020 New Report Available at ReportsnReports.com 3Health News:Spinal Surgery Market in North America Forecast to 2020 New Report Available at ReportsnReports.com 4Health News:LSE and ESC announce the launch of a new executive-style MSc 2Health News:Best of Breed: Barking Up a Storm for Petplan’s Annual Veterinary Awards 2Health News:Best of Breed: Barking Up a Storm for Petplan’s Annual Veterinary Awards 3Health News:More Than 10 Million People Gained Coverage Under Obamacare, Study Finds 2
... the initiation of a Phase 2a clinical trial for ... a novel , long-acting PDE-5 inhibitor being developed for ... as Raynaud's, a vasospastic disorder of small blood vessels ... areas such as the fingers and toes. Often triggered ...
... learning have found that boys and girls are different ... ,However, they have suggested that this dissimilar ... co-educational to segregated schools, or vice-versa. ,American ... in NSW, said that the key to this complexity ...
... abattoir, especially because it is afflicted with bovine TB. For a ... a heavy toll of the country's economy and prestige, sending the ... , But the "devout" Hindus of Carmarthenshire, a ... the reasoning of the Wales health authorities. The bull is ...
... kill a billion people this century, 10 times the toll it ... serious action to prevent it . ,Critics of smoking ban ... your lips will immediately kill you. And if you sniff-up someone ... in other words it is all over, forget retiring you will ...
... on the ancient Arctic ponds as well, according to new ... ,These ponds, which lie atop bedrock, freeze solid ... each summer, becoming hot spots of activity in the forbidding ... (a meter) deep and around several hundred feet across, the ...
... manned mission to Mars, it has taken its first shaky steps ... rid of the body of a dead astronaut on a three-year ... on a critically ill astronaut who is using up precious oxygen ... testing to weed out astronauts who might get a disease on ...
Cached Medicine News:Health News:Surface Logix Commences Phase 2a Clinical Trial of SLx-2101 in Raynaud's Disease 2Health News:Boys and Girls are Different by Nature and Learn in Different Ways 2Health News:Shambu With Bovine TB Being Prevented from Slaughter 2Health News:1 Billion People to Be Killed by Smoking 2Health News:Human Induced Global Warming Drying Up Arctic Ponds 2Health News:NASA Gets Ready To Address Tough Questions 2Health News:NASA Gets Ready To Address Tough Questions 3
The WellPro 384 is designed for use with 384 well microplates. It utilizes a 24 channel liquid head and can perform serial dilutions in a 16 or 24 across format, and plate to plate transfers and plat...
... 550 compound reformatter performs direct microplate-to-microplate ... nL using a new "touchless" transfer ... Monitoring of acoustic energy reflected from ... 550 to measure the water content ...
... liquid handling capability allows you to ... 5 nanoliters. Precision robotics and flexible ... so youll hit your target every ... without an air gap, providing increased ...
... System Genesis NPS based on the well-known ... to miniaturize your assays for high throughput ... direct dilutions., Furthermore it is an ... gene expression analysis, gene mapping, SNP detection ...
Medicine Products: